Kolexia
Meriaux Emeline
Oncologie médicale
Centre François-Baclesse
Caen, France
50 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Métastase tumorale Tumeurs de la prostate Tumeurs de l'ovaire Récidive tumorale locale Adénocarcinome Tumeurs de l'oesophage Tumeurs du col de l'utérus

Industries

Ipsen
12 collaboration(s)
Dernière en 2023
MSD
8 collaboration(s)
Dernière en 2023
AstraZeneca
4 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2023

Dernières activités

Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Therapeutic advances in urology   28 février 2024
AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
STARTER: A National, Multicenter, Phase III Randomized Controlled Trial to Assess the Impact of a One-year Supervised Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
Essai Clinique (Centre Léon-Bérard)   20 février 2024
TALASUR: TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma: A Single-arm Phase 2 Trial
Essai Clinique (Pfizer)   31 juillet 2023
Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Gynecologic oncology   19 mai 2023
CABOCOL-01: A Phase II Study Assessing Safety and Efficacy of Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure
Essai Clinique (Centre François-Baclesse)   10 février 2023
CHIPPI: Phase III Randomized Clinical Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer Considering Two Different Settings: Primary Debulking Surgery (PDS) and Interval Debulking Surgery (IDS)
Essai Clinique (Centre Oscar-Lambret)   06 décembre 2022
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC cancer   24 novembre 2022
Normalization of Liver Physiological Uptake as a Response Marker to Treatment in Prostate Cancer Liver Metastases Appearing as Photopenic on Baseline 18F-Fluorocholine PET/CT.
Clinical nuclear medicine   30 septembre 2022
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations.
Current oncology (Toronto, Ont.)   15 avril 2022